GO:0046474 glycerophospholipid biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046474 describes the biochemical routes that build glycerophospholipids, the dominant lipid class of eukaryotic membranes.
• The pathway supplies phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol and cardiolipin for membrane biogenesis and signalling.
• Glycerophospholipid biosynthesis is not a single linear route; it combines de novo synthesis with extensive acyl-chain remodeling.
• Viruses and intracellular pathogens hijack glycerophospholipid biosynthetic flux to build replication organelles.
• Dysregulated glycerophospholipid synthesis and remodeling are linked to metabolic syndrome, fatty liver disease and neurological disorders.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of each enzymatic step in the pathway.
Description
Glycerophospholipids are the principal structural lipids of biological membranes and are defined as derivatives of glycerophosphate carrying at least one O-acyl, O-alkyl or O-alkenyl group on the glycerol backbone. The Gene Ontology term GO:0046474, glycerophospholipid biosynthetic process, captures all chemical reactions and pathways that result in the formation of these molecules. Because membranes must grow, divide and remodel continuously, this process sits at the intersection of central carbon metabolism, lipid trafficking and cell signalling. The pathway is conserved from bacteria to humans, although the specific enzymes and acyl donors differ across taxa. For researchers, GO:0046474 is a practical annotation hub. It groups enzymes such as glycerol-3-phosphate acyltransferases, phosphatidate phosphatases, CDP-diacylglycerol synthases, phosphatidylserine synthases and phospholipases that generate or interconvert glycerophospholipid species. The term also covers acyl-chain remodeling, in which preformed phospholipids are deacylated and reacylated to achieve the mature acyl composition required for membrane function. This breadth makes the term useful for interpreting lipidomics, transcriptomics and CRISPR screens. Recent work shows that glycerophospholipid biosynthesis is not merely housekeeping. Orthoflavivirus infection depends on remodeling of the glycerophospholipid pool, and perturbation of these enzymes restricts viral replication. In metabolic disease, modulation of glycerophospholipid metabolism accompanies improvements in non-alcoholic fatty liver disease, and integrative lipidomics has linked altered glycerophospholipid profiles to metabolic syndrome in long-term treated HIV infection. These findings make GO:0046474 a high-value target for functional genomics.
glycerophospholipid biosynthetic process At A Glance
| GO ID | GO:0046474 |
|---|---|
| GO term | glycerophospholipid biosynthetic process |
| Ontology | biological_process |
| Definition | The chemical reactions and pathways resulting in the formation of glycerophospholipids, any derivative of glycerophosphate that contains at least one O-acyl, O-alkyl, or O-alkenyl group attached to the glycerol residue. |
| Synonyms | glycerophospholipid anabolism; glycerophospholipid biosynthesis; glycerophospholipid formation; glycerophospholipid synthesis; phosphoglyceride biosynthesis; phosphoglyceride biosynthetic process |
| Major function | Production and maturation of membrane glycerophospholipids for bilayer assembly, signalling and lipid storage |
| Substrates | Glycerol-3-phosphate, fatty acyl-CoAs, CDP-diacylglycerol, diacylglycerol, serine, inositol and choline |
| Key enzyme classes | Acyltransferases, phosphatases, CDP-diacylglycerol synthases, phospholipases and acyl-remodeling enzymes |
| Cellular locations | Endoplasmic reticulum, Golgi apparatus, mitochondria and lipid droplets |
What Is GO:0046474?
GO:0046474, glycerophospholipid biosynthetic process, is the set of chemical reactions and pathways that produce glycerophospholipids. A glycerophospholipid is any derivative of glycerophosphate that contains at least one O-acyl, O-alkyl or O-alkenyl group attached to the glycerol residue. In practice, the term covers de novo synthesis of the phosphatidate backbone, conversion of phosphatidate into CDP-diacylglycerol or diacylglycerol, and the subsequent formation of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol and cardiolipin, as well as the acyl-chain remodeling reactions that mature these lipids.
Why Is glycerophospholipid biosynthetic process Important in Cell Biology?
Glycerophospholipid biosynthesis determines the size, shape and permeability of every cellular membrane, and it supplies lipid second messengers and substrates for post-translational lipid modification. Because the pathway is essential, its enzymes are tightly regulated and are frequently rewired in infection, metabolic disease and cancer. Functional annotation under GO:0046474 therefore helps researchers connect lipidomic changes to specific enzymatic steps and to test causality with CRISPR models.
• Provides the bulk of membrane phospholipids required for cell growth and division.
• Supports replication organelle formation by orthoflaviviruses and other intracellular pathogens.
• Links central carbon metabolism to membrane lipid production through acyl-CoA pools.
• Contributes to metabolic syndrome and insulin resistance in chronic HIV infection.
• Is a therapeutic axis in non-alcoholic fatty liver disease and CD36-related lipid handling.
• Generates signalling lipids such as phosphatidic acid, diacylglycerol and lysophospholipids.
• Requires quality control of orphaned Golgi transmembrane proteins for correct enzyme localization.
• Shows taxonomic diversity in bacterial lipid biosynthesis, informing antimicrobial target selection.
• Is amenable to CRISPR knockout, point-mutation, knock-in and overexpression perturbation.
• Can be profiled by integrative lipidomics and metabolomics for system-level interpretation.
What Happens During glycerophospholipid biosynthetic process?
Step 1: Phosphatidate backbone formation
In simple terms: The cell first builds a simple lipid backbone called phosphatidate.
Glycerol-3-phosphate is acylated by glycerol-3-phosphate acyltransferases and then by 1-acylglycerol-3-phosphate acyltransferases to yield phosphatidate, the central intermediate of glycerophospholipid biosynthesis. The acyl-CoA donors used in these reactions are supplied by fatty acid synthesis and activation, linking glycerophospholipid production to central carbon metabolism. In bacteria, related acyltransferase steps generate the diverse glycerophospholipid species that define each membrane system.
Step 2: Branching from phosphatidate to CDP-diacylglycerol or diacylglycerol
In simple terms: Phosphatidate is converted into one of two activated intermediates that feed different arms of the pathway.
Phosphatidate can be converted to CDP-diacylglycerol by CDP-diacylglycerol synthase, or dephosphorylated to diacylglycerol by phosphatidate phosphatase. The CDP-diacylglycerol arm supplies phosphatidylinositol, phosphatidylglycerol and cardiolipin, whereas the diacylglycerol arm supplies phosphatidylcholine and phosphatidylethanolamine through the Kennedy pathway. This branch point is a major regulatory node because the two arms compete for the same phosphatidate pool.
Step 3: Head-group decoration and phospholipid class synthesis
In simple terms: Different head groups are attached to the lipid backbone to create the various phospholipid classes.
CDP-diacylglycerol is used by phosphatidylinositol synthase and phosphatidylglycerophosphate synthase to form phosphatidylinositol and phosphatidylglycerol, the latter being a precursor of cardiolipin in mitochondria. In the Kennedy pathway, diacylglycerol is converted to phosphatidylcholine or phosphatidylethanolamine by choline and ethanolamine phosphotransferases, and phosphatidylserine is produced by base-exchange reactions. These reactions determine the phospholipid class composition of each membrane.
Step 4: Acyl-chain remodeling and membrane maturation
In simple terms: After the basic phospholipid is made, its fatty acid tails are swapped to reach the mature composition.
Newly synthesized glycerophospholipids undergo deacylation and reacylation cycles that introduce specific acyl chains, a process often called Lands cycle remodeling. Phospholipase A2 enzymes remove acyl chains to generate lysophospholipids, which are then reacylated by acyltransferases. Orthoflavivirus infection depends on this remodeling step, and perturbation of remodeling enzymes impairs viral replication. Remodeling also determines membrane curvature, thickness and protein interactions.
Step 5: Trafficking and quality control of pathway enzymes
In simple terms: The enzymes that make lipids must reach the right membrane, and cells degrade them if they fail to fold or assemble.
Glycerophospholipid biosynthetic enzymes are integral membrane proteins of the endoplasmic reticulum, Golgi and mitochondria, and their correct localization depends on membrane protein quality control. The Dsc ubiquitin ligase complex recognizes transmembrane degrons and targets orphaned Golgi proteins for degradation, preventing unassembled enzymes from accumulating. This quality-control layer indirectly shapes the capacity of the cell to synthesize glycerophospholipids.
Key Genes Involved in GO:0046474 glycerophospholipid biosynthetic process
The following genes and enzyme families represent core, well-annotated contributors to glycerophospholipid biosynthetic process and are commonly perturbed in functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPAT1 | Glycerol-3-phosphate acyltransferase initiating phosphatidate synthesis | Knockout models test hepatic glycerophospholipid flux and steatosis |
| AGPAT1 | Acylates lysophosphatidate to form phosphatidate | Point mutations probe substrate specificity and pathway flux |
| LPIN1 | Phosphatidate phosphatase converting phosphatidate to diacylglycerol | Knockout links phosphatidate balance to lipid signalling |
| CDS1 | CDP-diacylglycerol synthase for the PI/PG arm | Overexpression increases CDP-diacylglycerol and acidic phospholipids |
| CDS2 | CDP-diacylglycerol synthase isoform | Knockout reveals isoform-specific membrane requirements |
| PIS1 | Phosphatidylinositol synthase | Knock-in tagging enables localization studies |
| PGS1 | Phosphatidylglycerophosphate synthase | Knockout affects cardiolipin and mitochondrial function |
| CEPT1 | Choline/ethanolamine phosphotransferase | Knockout alters phosphatidylcholine and phosphatidylethanolamine ratios |
| CHKA | Choline kinase in the Kennedy pathway | Overexpression increases phosphatidylcholine synthesis |
| ETNK1 | Ethanolamine kinase in the Kennedy pathway | Point mutations are studied in metabolic and haematological models |
| PSS1 | Phosphatidylserine synthase 1 | Knockout changes phosphatidylserine and signalling lipids |
| PLA2G4A | Cytosolic phospholipase A2 initiating acyl remodeling | Knockout and inhibitors test remodeling-dependent phenotypes |
| LPCAT1 | Lysophosphatidylcholine acyltransferase for reacylation | Overexpression modifies membrane acyl composition |
| LPGAT1 | Lysophosphatidylglycerol acyltransferase | Knockout probes cardiolipin maturation |
| TAZ | Cardiolipin transacylase | Mutations cause Barth syndrome-like lipid defects |
| MBOAT7 | Lysophosphatidylinositol acyltransferase | Knockout links remodeling to liver disease |
| SCD1 | Desaturase supplying unsaturated acyl-CoAs | Knockout changes glycerophospholipid acyl saturation |
How Is glycerophospholipid biosynthetic process Regulated?
Glycerophospholipid biosynthetic process is regulated at multiple levels. Transcription of Kennedy pathway enzymes responds to choline and ethanolamine availability, while phosphatidate phosphatase and CDP-diacylglycerol synthase activities are controlled by phosphorylation and membrane lipid environment. Acyl-CoA supply from fatty acid synthesis and oxidation sets the substrate ceiling for acylation reactions, and metabolic signals such as succinylation can influence resource allocation toward lipid biosynthesis. Protein quality control at the Golgi removes orphaned transmembrane enzymes, adding a post-translational layer that limits pathway capacity. Phospholipase A2 activity controls the remodeling arm and generates lysophospholipid signals that feed back on synthesis.
glycerophospholipid biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MBOAT7 | Liver disease and glycerophospholipid remodeling | Hepatocyte knockout with lipidomics readout |
| CD36 | NAFLD and fatty acid uptake linked to glycerophospholipid metabolism | CRISPR-Cas9 knockout in liver models |
| PLA2G4A | Inflammatory signalling through lysophospholipid production | Point-mutation knock-in of catalytic-dead allele |
| TAZ | Cardiolipin remodeling and mitochondrial myopathy | Knock-in of patient variants in cardiomyocytes |
| GPAT1 | Hepatic steatosis and acyl-CoA partitioning | Overexpression and knockout in hepatocytes |
Metabolic syndrome and HIV-associated dyslipidemia
Integrative lipidomics and metabolomics in long-term treated HIV-infected individuals identified glycerophospholipid species as central nodes of metabolic syndrome, linking altered biosynthesis and remodeling to insulin resistance and cardiovascular risk. These findings support the use of glycerophospholipid profiling as a systems-level readout in metabolic disease.
Non-alcoholic fatty liver disease
Lipid nanoparticle-mediated CRISPR-Cas9 targeting of Rubicon ameliorated non-alcoholic fatty liver disease in models, and the beneficial effect was accompanied by modulation of CD36 and glycerophospholipid metabolism. This connects glycerophospholipid biosynthetic flux to hepatic lipid handling and suggests pathway enzymes as therapeutic entry points.
Viral infection and replication organelle formation
Glycerophospholipid remodeling is critical for orthoflavivirus infection, and viruses reorganize host glycerophospholipid biosynthesis to build replication organelles. Inhibiting remodeling enzymes reduces viral replication, making the pathway a host-directed antiviral target.
Neurological and mitochondrial lipid disorders
Cardiolipin and other mitochondria-specific glycerophospholipids are products of the CDP-diacylglycerol arm, and defects in their synthesis or remodeling are associated with mitochondrial dysfunction in neurological and neuromuscular disease. Bacterial lipid diversity studies further show how essential these pathways are across taxa.
From glycerophospholipid biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is an enzyme required for glycerophospholipid synthesis? | CRISPR knockout of the candidate gene with lipidomic profiling |
| Does a catalytic residue drive acyl transfer? | Point mutation of the active-site residue followed by substrate flux assays |
| How does a disease variant alter pathway flux? | Knock-in of the patient allele in an isogenic cell line |
| Where does the enzyme localize and interact? | Tagged knock-in with fluorescent or affinity tag |
| Does increased pathway capacity change membrane composition? | Overexpression of the rate-limiting enzyme |
| Which genes buffer loss of a pathway enzyme? | CRISPR library screening with lipid-sensitive selection |
How to Study the glycerophospholipid biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Shotgun lipidomics | Glycerophospholipid class and species abundance | Pathway flux after CRISPR perturbation |
| Targeted metabolomics | Glycerol-3-phosphate, CDP-diacylglycerol and acyl-CoA pools | Substrate limitation studies |
| RNA sequencing | Expression of biosynthetic and remodeling enzymes | Transcriptional response to lipid stress |
| Proteomics | Enzyme abundance and post-translational modifications | Succinylation and quality-control studies |
| Fluorescence microscopy | Enzyme localization and organelle morphology | Golgi and ER trafficking studies |
| Pulse-chase labeling | De novo synthesis and remodeling rates | Kinetic analysis of pathway steps |
| Enzyme activity assay | Catalytic rate of acyltransferases and phospholipases | Variant functional validation |
| CRISPR library screening | Genes required for pathway-dependent growth | Discovery of buffering networks |
Lipidomics and metabolomics
Mass spectrometry-based lipidomics quantifies glycerophospholipid species and their acyl compositions, while metabolomics captures water-soluble precursors such as glycerol-3-phosphate and CDP-diacylglycerol. Integrative analysis of both layers provides a system-level view of pathway flux and has been applied to metabolic syndrome cohorts.
Transcriptomics and proteomics
RNA sequencing measures expression of glycerophospholipid biosynthetic enzymes, and proteomics quantifies their abundance and post-translational modifications. Succinylation profiling has revealed metabolism-dependent regulation of resource allocation, including lipid biosynthetic enzymes.
Imaging and subcellular localization
Fluorescence imaging of tagged enzymes and lipid probes reveals where glycerophospholipid synthesis occurs and how it responds to perturbation. Quality-control studies use imaging to track orphaned Golgi transmembrane proteins and their degradation.
Enzymatic and flux assays
In vitro assays with radiolabeled or fluorescent substrates measure acyltransferase, phosphatase and phospholipase activities, while pulse-chase labeling estimates de novo synthesis and remodeling rates. These assays validate causal claims from CRISPR perturbation.
How CRISPR Can Be Used to Study GO:0046474 glycerophospholipid biosynthetic process
Knockout
CRISPR knockout of glycerophospholipid biosynthetic genes such as GPAT1, CDS1 or MBOAT7 removes the enzymatic step and reveals its contribution to membrane composition and disease phenotypes. Knockout models are typically validated by lipidomics and rescue experiments.
Point Mutation
Point mutation of catalytic residues or regulatory phosphorylation sites separates enzymatic activity from scaffolding functions. For phospholipases, catalytic-dead knock-in alleles distinguish lipid remodeling from protein-protein interactions.
Knock-in
Knock-in of disease-associated variants or epitope tags allows allele-specific analysis of glycerophospholipid biosynthetic enzymes in an isogenic background. Tagged knock-in lines support localization and interactome studies.
Overexpression
Overexpression of rate-limiting enzymes increases pathway capacity and can drive membrane lipid changes, as shown for choline kinase and CDP-diacylglycerol synthases. Overexpression models are useful for testing sufficiency in disease contexts.
How EDITGENE Supports glycerophospholipid biosynthetic process Research
Researchers studying glycerophospholipid biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in lipid synthesis, remodeling or disease. EDITGENE provides publication-ready CRISPR cell models and screening services that let you move from correlation to mechanism with validated reagents.
Contact EDITGENE today to design your custom CRISPR model for glycerophospholipid biosynthetic process research.
Frequently Asked Questions About glycerophospholipid biosynthetic process
What is glycerophospholipid biosynthetic process?
It is the set of biochemical reactions that produce glycerophospholipids, the main structural lipids of cell membranes, as defined by GO:0046474.
What genes are involved in glycerophospholipid biosynthetic process?
Genes include GPAT1, AGPAT1, LPIN1, CDS1, CDS2, PIS1, PGS1, CEPT1, CHKA, ETNK1, PSS1, PLA2G4A, LPCAT1, LPGAT1, TAZ, MBOAT7 and SCD1.
Why is glycerophospholipid biosynthesis important for cells?
It supplies membrane lipids for growth, division and signalling, and its products shape organelle identity and protein function.
How is glycerophospholipid biosynthesis regulated?
It is regulated by substrate availability, enzyme phosphorylation, acyl-CoA supply, protein quality control and phospholipase-mediated remodeling.
What diseases are linked to glycerophospholipid metabolism?
Metabolic syndrome, non-alcoholic fatty liver disease, viral infection and mitochondrial lipid disorders have been linked to altered glycerophospholipid synthesis or remodeling.
Which viruses depend on glycerophospholipid remodeling?
Orthoflaviviruses depend on glycerophospholipid remodeling for infection and replication organelle formation.
What methods study glycerophospholipid biosynthetic process?
Lipidomics, metabolomics, RNA sequencing, proteomics, imaging, enzyme assays and CRISPR screens are commonly used.
Can CRISPR knockout be used to study glycerophospholipid enzymes?
Yes, CRISPR knockout of pathway genes followed by lipidomic profiling is a standard approach to test causality.
What is the role of phospholipase A2 in this pathway?
Phospholipase A2 removes acyl chains from glycerophospholipids, generating lysophospholipids that are reacylated during remodeling.
How does the Golgi quality-control system affect glycerophospholipid synthesis?
The Dsc ubiquitin ligase complex degrades orphaned Golgi transmembrane proteins, limiting accumulation of unassembled biosynthetic enzymes.
Conclusion
GO:0046474 glycerophospholipid biosynthetic process is a central biological process that builds and matures the glycerophospholipid complement of every membrane. Its enzymes are conserved, essential and frequently rewired in infection, metabolic disease and mitochondrial disorders. Combining lipidomics with CRISPR perturbation provides a direct route from gene to pathway flux to phenotype. EDITGENE supports this workflow with validated knockout, point-mutation, knock-in, overexpression and screening models for glycerophospholipid research.
References
- 1. Wu JH et al.. 2025. Metabolism-dependent succinylation governs resource allocation for antibiotic resistance.. Sci Adv 11(34):eadu2856 PMID: 40845110
- 2. Hehner J et al.. 2024. Glycerophospholipid remodeling is critical for orthoflavivirus infection.. Nat Commun 15(1):8683 PMID: 39375358
- 3. Weyer Y et al.. 2024. The Dsc ubiquitin ligase complex identifies transmembrane degrons to degrade orphaned proteins at the Golgi.. Nat Commun 15(1):9257 PMID: 39461958
- 4. López-Lara IM et al.. 2017. Bacterial lipid diversity.. Biochim Biophys Acta Mol Cell Biol Lipids 1862(11):1287-1299 PMID: 27760387
- 5. Bai Y et al.. 2024. Lipid Nanoparticle-Mediated Delivery of CRISPR-Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism.. Adv Sci (Weinh) 11(31):e2400493 PMID: 38894572
- 6. Olund Villumsen S et al.. 2021. Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals.. Front Immunol 12:742736 PMID: 35095835
- 7. Chauhan N et al.. 2016. Lipid topogenesis--35years on.. Biochim Biophys Acta 1861(8 Pt B):757-766 PMID: 26946259
- 8. Murakami M et al.. 2020. Updating Phospholipase A(2) Biology.. Biomolecules 10(10) PMID: 33086624
